Coagulation Factor Concentrates Market by Type of Coagulation Factor (Factor IX (FIX) concentrates, Factor VII (FVII) concentrates, Factor VIII (FVIII) concentrates), Product Formulation (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagula

Coagulation Factor Concentrates Market by Type of Coagulation Factor (Factor IX (FIX) concentrates, Factor VII (FVII) concentrates, Factor VIII (FVIII) concentrates), Product Formulation (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates), Application, End-User - Global Forecast 2024-2030


The Coagulation Factor Concentrates Market size was estimated at USD 8.66 billion in 2023 and expected to reach USD 8.84 billion in 2024, at a CAGR 7.46% to reach USD 14.34 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Coagulation Factor Concentrates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Coagulation Factor Concentrates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Factor Concentrates Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bio Products Laboratory Limited, BIOGEN INC., Biotest AG., Cerus Corporation, Emergent BioSolutions Inc., Kedrion S.p.A, LFB USA, Medscape Network, Novo Nordisk A/S, Octapharma USA, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage


This research report categorizes the Coagulation Factor Concentrates Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type of Coagulation Factor
Factor IX (FIX) concentrates
Factor VII (FVII) concentrates
Factor VIII (FVIII) concentrates
Factor XIII (FXIII) concentrates
Product Formulation
Plasma-Derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Application
Hemophilia Treatment
Surgical Procedures
End-User
Homecare Settings
Hospitals
Specialty Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Coagulation Factor Concentrates Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Coagulation Factor Concentrates Market?
3. What are the technology trends and regulatory frameworks in the Coagulation Factor Concentrates Market?
4. What is the market share of the leading vendors in the Coagulation Factor Concentrates Market?
5. Which modes and strategic moves are suitable for entering the Coagulation Factor Concentrates Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Coagulation Factor Concentrates Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of hemophilia and clotting deficiencies
5.1.1.2. Increase in biotechnology R&D to develop effective coagulation factor concentrates
5.1.1.3. Inclination toward early diagnosis and treatment of diseases
5.1.2. Restraints
5.1.2.1. Contamination issues associated with the synthesis of coagulation factor concentrate
5.1.3. Opportunities
5.1.3.1. Introduction of improved coagulation factor concentrates
5.1.3.2. Significant advancements in gene therapy
5.1.4. Challenges
5.1.4.1. Stringent regulatory procedure for product approval
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Coagulation Factor Concentrates Market, by Type of Coagulation Factor
6.1. Introduction
6.2. Factor IX (FIX) concentrates
6.3. Factor VII (FVII) concentrates
6.4. Factor VIII (FVIII) concentrates
6.5. Factor XIII (FXIII) concentrates
7. Coagulation Factor Concentrates Market, by Product Formulation
7.1. Introduction
7.2. Plasma-Derived Coagulation Factor Concentrates
7.3. Recombinant Coagulation Factor Concentrates
8. Coagulation Factor Concentrates Market, by Application
8.1. Introduction
8.2. Hemophilia Treatment
8.3. Surgical Procedures
9. Coagulation Factor Concentrates Market, by End-User
9.1. Introduction
9.2. Homecare Settings
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Coagulation Factor Concentrates Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Coagulation Factor Concentrates Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Coagulation Factor Concentrates Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Bayer AG
14.1.2. Bio Products Laboratory Limited
14.1.3. BIOGEN INC.
14.1.4. Biotest AG.
14.1.5. Cerus Corporation
14.1.6. Emergent BioSolutions Inc.
14.1.7. Kedrion S.p.A
14.1.8. LFB USA
14.1.9. Medscape Network
14.1.10. Novo Nordisk A/S
14.1.11. Octapharma USA, Inc.
14.1.12. Pfizer Inc.
14.1.13. Takeda Pharmaceutical Company Limited
14.1.14. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. COAGULATION FACTOR CONCENTRATES MARKET RESEARCH PROCESS
FIGURE 2. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2023 VS 2030
FIGURE 3. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COAGULATION FACTOR CONCENTRATES MARKET DYNAMICS
FIGURE 7. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2030 (%)
FIGURE 8. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2030 (%)
FIGURE 10. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings